Expert Review of Clinical Pharmacology

Article	Citations
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock	186
Safety assessment of propranolol for infantile hemangioma: a study in an Asian population	165
Dasiglucagon for treating severe hypoglycemia in patients with diabetes	53
The continuum of care of anticancer treatment-induced hypothyroidism in patients with solid non-thyroid tumors: time for an intimate collaboration between oncologists and endocrinologists	42
Regional variation in longitudinal trajectories of primary care opioids prescribing across Health Boards in Scotland: a population-based study	42
Effectiveness and safety of thiopurines in inflammatory bowel disease patients with NUDT15 polymorphism: a real-world retrospective study	40
Tocilizumab for the treatment of non‐critical COVID‐19 pneumonia: an overview of the rationale and clinical evidence to date	39
Clinical pharmacology of antiplatelet drugs	39
Exploring the room for repurposed hydroxychloroquine to impede COVID-19: toxicities and multipronged combination approaches with pharmaceutical insights	35
Pharmacological and clinical profile of ravulizumab 100 mg/mL formulation for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome	33
Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials	29
Telmisartan (and/or nitrosamine) - induced occult melanoma: first reported case in world literature	29
Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled tr	29
The use of oral GnRH antagonists to inhibit the LH surge in women undergoing ovarian stimulation for in vitro fertilization	27
Strategies for lowering lipoprotein(a): a spotlight on novel pharmacological treatments	27
Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis	27
Sodium-glucose co-transporter 2 inhibition and acute myocardial infarction: the DAPA-MI and EMPACT-MI trials	26
Immune checkpoint inhibition of metastatic melanoma: achieving high efficacy in the face of high toxicity	26
Reliance is key to effective access and oversight of medical products in case of public health emergencies	25
Comparison of weight loss and adverse events of obesity drugs in children and adolescents: a systematic review and meta-analysis	24
The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers	23
Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury	22
A review of recent advances in the treatment of adults with complicated urinary tract infection	21
Effectiveness of statins in people living with HIV: a systematic review and meta-analysis of randomized controlled trials	21
JAK inhibitors in vitiligo: what they hit and what they miss - an immunopathogenesis based exposition of existing evidence	20

Advances in pharmacokinetic-pharmacodynamic modelling for pediatric drug development: extrapolations and exposure-response analyses	19
Determinants of adherence to treatment in patients with ophthalmic conditions	19
Samidorphan for the treatment of weight gain associated with olanzapine in patients with schizophrenia and bipolar disorder	18
Adverse clinical outcomes associated with drug-related hospitalizations in people with dementia	18
Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed	18
Comparing immunotherapies to other frequently used treatments of gastric cancer	17
Sodium-glucose cotransporter 2 inhibitors in frail, older people with type 2 diabetes and heart failure: do we have enough evidence to confidently support the use?	17
Clinical outcomes of oral anticoagulant discontinuation in atrial fibrillation: a systematic review and meta-analysis	17
Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications	16
Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids	16
Biologics and small molecules in the management of psoriatic arthritis: Reproduction related issues in female and male patients	16
Pharmacological treatment for transforming growth factor beta induced corneal dystrophies: what is the way forward?	16
Gene therapy in cardiology: pioneering a new era in medical ethics and patient care	15
Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS	15
Updates in innovation of the treatment of pyoderma gangrenosum	15
A scoping review of legibility of hand-written prescriptions and drug-orders: the writing on the wall	15
Personalizing tamoxifen therapy in adjuvant therapy: a brief summary of the ongoing discussion	14
The era of lenalidomide maintenance therapy in multiple myeloma: settings for achieving best outcomes	14
Prostate cancer and novel pharmacological treatment options–what’s new for 2022?	14
Availability and evaluation of medication management resources for carers of people with dementia: a scoping review with an environmental scan	14
Pharmacological approaches to prevent vertical transmission of HIV and HBV	14
Sotagliflozin and decompensated heart failure: results of the SOLOIST-WHF trial	13
Inhaler technique in asthma and COPD: challenges and unmet knowledge that can contribute to suboptimal use in real life	13
Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia	13
Edoxaban for the treatment of pulmonary embolism in hospitalized COVID-19 patients	13
Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks	13
Keeping up with venetoclax for leukemic malignancies: key findings, optimal regimens, and clinical considerations	13
Genetic markers of drug hypersensitivity in pediatrics: current state and promise	12
The future of pharmacology education: The Veterinary Educators in Pharmacology Special Interest Group (VEPSIG)	12
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications	12
Emerging insights and future prospects for therapeutic application of siRNA targeting angiotensinogen in hypertension	12
Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers	12
Why is diagnosis, investigation, and improved management of kidney stone disease important? Non-pharmacological and pharmacological treatments for nephrolithiasis	12
Efficacy of pharmacological agents for the management of treatment-resistant schizophrenia: a network meta-analysis	12
Reducing the risk of death – a possible outcome in COPD patients	12
Current understanding of the etiology of cyclic vomiting syndrome and therapeutic strategies in its management	12
Classes of drugs that target the cellular components of inflammation under clinical development for COPD	11
The effect of different contraceptive methods on the vaginal microbiome	11
JAK inhibitors in dermatology: the road travelled and path ahead, a narrative review	11
Pharmacological profile of once-weekly injectable semaglutide for chronic weight management	11
A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia	10
Correction	10
Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase	10
Proton pump inhibitors may reduce the risk of high-grade dysplasia and/or esophageal adenocarcinoma in Barrett’s esophagus: a systematic review and meta-analysis	10
Clozapine for treatment refractory catatonia in individuals with autism spectrum disorder: a retrospective chart review study	10
Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system	10
Short-acting versus long-acting opioids for pediatric postoperative pain management	10
Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma	10
Effect of Wuzhi capsules on cyclosporine A concentration in children with aplastic anemia immunotherapy: a single-center observational study	10
The pharmacotherapeutics of sarcoidosis	9

Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities	9
Overcoming blinding confounds in psychedelic randomized controlled trials using biomarker driven causal mediation analysis	9
Therapeutic drug monitoring of antiretroviral therapy: current progresses and future directions	9
What is novel in the clinical management of pemphigus vulgaris?	9
Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trial	9
Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy	9
The efficacy of vitamin D in treatment of fibromyalgia: a meta-analysis of randomized controlled studies and systematic review	9
Prediction of vancomycin dose on high-dimensional data using machine learning techniques	9
What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion	9
Significant predictors for olanzapine pharmacokinetics: a systematic review of population pharmacokinetic studies	9
STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: uptake and clinical impact	9
Blinding and expectancy confounds in psychedelic randomized controlled trials	9
Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause	9
Safety of drugs used for the treatment of migraine during pregnancy: a narrative review	9
Do patients with immune-mediated thrombotic thrombocytopenic purpura receiving caplacizumab need antithrombotic therapy?	8
Immunotherapy for the treatment of metastatic small cell lung cancer: Focus on pembrolizumab	8
Response to letter to the editor: therapeutic importance of proteinuria classification in children with congenital anomalies of the kidney and urinary tract	8
Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials	8
Intravitreal immunotherapy in non-infectious uveitis: an update	8
Perspectives on deprescribing in older people with type 2 diabetes and/or cardiovascular conditions: challenges from healthcare provider, patient and caregiver perspective, and interventions to suppor	8
Clinical considerations when switching antiretroviral therapy	8
Targeting the spectrum of immune checkpoints in prostate cancer	8
Novel and emerging treatment strategies for lupus nephritis	8
Role of tenecteplase in ischemic stroke after 4.5 hours: an evaluation of the TRACE-III trial	7
Parametric population pharmacokinetics of isoniazid: a systematic review	7
Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection	7
The impact of body composition on treatment in ovarian cancer: a current insight	7
Epoprostenol for the treatment of pulmonary arterial hypertension	7
Predicting plasma concentration of quetiapine in patients with depression using machine learning techniques based on real-world evidence	7
Is ranitidine necessary as premedication for regimens containing paclitaxel? A non-inferiority study	7
Cannabidiol drug interaction considerations for prescribers and pharmacists	7
Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease	7
Colony stimulating factors for prophylaxis of chemotherapy-induced neutropenia in children	7
A comprehensive strategy to address shortage of Erwinia asparaginase in pediatric acute lymphoblastic leukemia	7
Growing role of SGLT2i in heart failure: evidence from clinical trials	7
Intraperitoneal therapy for gastric cancer peritoneal carcinomatosis	7
Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions	7
Correction	7
Therapeutic drug monitoring of carbapenem antibiotics in critically ill patients: an overview of principles, recommended dosing regimens, and clinical outcomes	7
Comparing the renal outcomes in patients with atrial fibrillation receiving different oral anticoagulants	7
Givosiran for the treatment of acute hepatic porphyria	7
Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview	7
Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literature	7
Engaging patients in conversations about deprescribing	7
Published population pharmacokinetic models of valproic acid in adult patients: a systematic review and external validation in a Chinese sample of inpatients with bipolar disorder	7
Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin	6
Perspectives on deprescribing in palliative care	6
Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes	6
The outcomes of goal-oriented medication reviews for the elderly: current research and future directions	6
Snakebite-associated thrombotic microangiopathy: a spotlight on pharmaceutical interventions	6
Considerations when prescribing opioid agonist therapies for people living with HIV	6
Hugan tablets for the treatment of RUCAM based drug-induced liver injury: a propensity score matching analysis using a nationwide database	6
Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors	6
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations	6
The effect of vitamin D supplementation on glycemic status of elderly people with prediabetes: a 12-month open-label, randomized-controlled study	6
Correction	6
The effect of different levothyroxine administration regimens on thyroid hormone levels: a systematic review, pairwise, and network meta-analysis	6
Oral complement factor D inhibitor danicopan for paroxysmal nocturnal hemoglobinuria	6
Effect of fasudil on clinical outcomes of pulmonary hypertension: a systematic review and meta-analysis	6
Dostarlimab for the treatment of advanced endometrial cancer	6
Optimizing ganciclovir and valganciclovir dosing regimens in pediatric patients with cytomegalovirus infection: a spotlight on therapeutic drug monitoring	6
Fetal safety of medications used in treating infertility	6
The association between ACE inhibitors and psoriasis based on the drug-targeted Mendelian randomization and real-world pharmacovigilance analyses	6
Amylin analogs for the treatment of obesity without diabetes: present and future	6
UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions	6
Optimizing outcomes and managing adverse events in locally advanced or metastatic urothelial cancer: a clinical pharmacology perspective	6
Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria	5
Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations	5
Germline genetic variations in methotrexate pathway are associated with pharmacokinetics, outcome, and toxicity in patients with primary central nervous system lymphoma	5
OPTIMA-ID: development and validation of a medicine optimization tool for older adults with intellectual disability	5
Quantitative efficacy of L-carnitine supplementation on glycemic control in type 2 diabetes mellitus patients	5
A review of alternative intravenous acetylcysteine regimens for acetaminophen overdose	5
The changes of IgE levels in type 2 inflammatory diseases after treatment of dupilumab: a systematic review and meta-analysis	5
Extending the ambit of SGLT2 inhibitors beyond diabetes: a review of clinical and preclinical studies on non-diabetic kidney disease	5
The pharmacology of anticoagulant drug treatment options in COVID-19 patients: reviewing real-world evidence in clinical practice	5
Quantitative effects of sodium-glucose cotransporter-2 inhibitors on liver functions in patients with nonalcoholic fatty liver disease	5
131-I-metaiodobenzylguanidine and chemotherapy for advanced neuroblastoma	5
Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19	5
Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis	5
Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogens	5

Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns	5
Biosimilar development and review process in the BRICS-TM countries: Proposal for a standardized model to improve regulatory performance	5
Recent pharmacological approaches for the treatment of renal cell carcinoma	5
Changing landscapes and increasing relevance of immunotherapy in localized MSI-H gastric adenocarcinoma	5
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives	5
Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients	5
The coincidence of increased risk of atrial fibrillation in randomized control trials of omega-3 fatty acids: a meta-analysis	5
Population pharmacokinetics and model-informed precision dosing of lamivudine in Chinese HIV-infected patients with mild and moderate impaired renal function	5
Switching of oral anticoagulants in atrial fibrillation: a cohort study using Australian general practice data	4
Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk	4
Lactic acid, citric acid, and potassium bitartrate non-hormonal prescription vaginal pH modulator (VPM) gel for the prevention of pregnancy	4
Person-centeredness in medication management with people living with dementia	4
UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder	4
Recent advances in the treatment of childhood asthma: a clinical pharmacology perspective	4
Therapeutic drug monitoring-guided dosing for pediatric cystic fibrosis patients: recent advances and future outlooks	4
Plasma protein binding of arsenic species in acute promyelocytic leukemia patients and their relationships with hepatic and renal function	4
Incidence and risk of severe adverse events associated with trastuzumab emtansine (T-DM1) in the treatment of breast cancer: an up-to-date systematic review and meta-analysis of randomized controlled	4
Treatment and prevention of influenza in geriatric patients	4
Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis	4
Understanding the efficacy and tolerability of migraine treatment: a deep dive into CGRP antagonists	4
Nephroprotective effects of febuxostat and/or mirtazapine against gentamicin-induced nephrotoxicity through modulation of ERK 1/2, NF-κB and MCP1	4
The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease	4
Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder	4
Evinacumab for the treatment of homozygous familial hypercholesterolemia	4
Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis	4
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study	4
Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma	4
Safety and efficacy of therapies for chylomicronemia	4
BMI but not age and sex negatively impact on the outcome of pharmacotherapy in fibromyalgia: a systematic review	4
Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD)	4
Vaccination and their importance for lung transplant recipients in a COVID-19 world	4
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update	3
Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics	3
Commonly used immunosuppressive drugs for kidney diseases and pregnancy: focus on open questions	3
Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?	3
Scoping review of the availability and uptake of disease modifying therapies in children and adolescents with multiple sclerosis	3
Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	3
Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice	3
The expert clinical pharmacological advice program for tailoring on real-time antimicrobial therapies with emerging TDM candidates in special populations: how the ugly duckling turned into a swan	3
Population pharmacokinetics of nirmatrelvir/ritonavir in critically ill Chinese COVID-19 patients and recommendations for medication use: a two-center retrospective study	3
Updates in the diagnosis and practical management of allergic rhinitis	3
The impact of pregnancy-related hormonal and physiological changes on antiseizure medications: expert perspective	3
Pharmacological strategies for the management of the antisocial personality disorder	3
Reply to: The risk for genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter?	3
An update on drug–drug interactions in older adults living with human immunodeficiency virus (HIV)	3
Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspective	3
Next-generation sequencing in pharmacogenomics – fit for clinical decision support?	3
Influence of N -acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients	3
The role of the alternative pathway in paroxysmal nocturnal hemoglobinuria and emerging treatments	3
Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders	3
Artificial intelligence and machine learning in clinical pharmacological research	3
Renin–angiotensin system inhibition and mortality in patients undergoing dialysis with coronary artery disease: insights from a multi-center observational study	3
Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era	3
The risk of genito-urinary infections with sodium-glucose cotransporter-2 inhibitors: duration rather than dose matter?	3
A systematic review and meta-analysis of the effect of statin treatment on sVCAM-1 and sICAM-1	3
Optimizing meropenem therapy in critical infections: a review of pharmacokinetics/pharmacodynamics research and clinical practice	3
Therapeutic drug monitoring in acute lymphoblastic leukemia–a deep dive into pharmacokinetics, -dynamics, and -genetics of antileukemic drugs	3
Complications related to oral corticosteroid use in asthma patients: a retrospective cohort study	3
An overview of new and emerging antibody therapies for moderate-severe atopic dermatitis in adults	3
Recent advances in clearance monitoring of monoclonal antibodies in patients with inflammatory bowel diseases	3
Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis	3
Heparin infusions in aneurysmal subarachnoid hemorrhages: clinical considerations for use beyond anticoagulation	3
Clinical pharmacology of β-3 adrenergic receptor agonists for cardiovascular diseases	3
Implementing pharmacogenetics in clinical trials: considerations about current methodological, ethical, and regulatory challenges	3
Challenges, unmet needs and future directions – a critical evaluation of the clinical trial landscape in schizophrenia research	2
The effect of epilepsy and antiseizure medications on cardiac autonomic functions in children with epilepsy	2
Tirzepatide, a novel, dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonist for the ongoing diabesity epidemic: the dawn of a new era?	2
Closing the gaps in the access to quality-assured medicines for global health: The case for oxytocin for postpartum haemorrhage	2
Population pharmacokinetic modeling and exposure-response analysis of anrikefon: insights and implications in clinical analgesia	2
Comparative effectiveness and safety of inhaled corticosteroid plus long-acting β 2 -agonist fixed-dose combinations vs. long-acting muscarinic antagonist in bronchi	2
Hydroxyurea in the sickle cell disease modern era	2
Targeting HIF-2α: the role of belzutifan in clear cell renal carcinoma management	2
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs	2
Coadministration of silymarin with iron chelators in transfusion-dependent β-thalassemia patients: a systematic review and meta-analysis for effect on iron overload	2
Enhancing readability of USFDA patient communications through large language models: a proof-of-concept study	2
Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists	2
Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts’ perspective	2
The search for blood biomarkers useful in treating atopic dermatitis patients	2
Time to incorporate preemptive NUDT15 testing before starting thiopurines in inflammatory bowel disease in Asia and beyond: a review	2
Type II RAF inhibitor tovorafenib for the treatment of pediatric low-grade glioma	2
Effect of renal impairment on arsenic accumulation, methylation capacity, and safety in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide	2
Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation	2
Therapeutic approach to difficult-to-treat typical absences and related epilepsy syndromes	2
Messenger interference RNA therapies targeting apolipoprotein C-III and angiopoietin-like protein 3 for mixed hyperlipidemia: the future of plozasiran and zodasiran	2
Type of proteinuria might be essential for RAAS-I treatment in children with CAKUT	2
Mechanism-based pharmacokinetic and pharmacodynamic modeling for bispecific antibodies: challenges and opportunities	2
The need for inhaled phosphodiesterase inhibitors in chronic obstructive pulmonary disease	2
A scoping review of the clinical utility of adverse drug reaction causality analysis tools for use in the hospital setting	2
Analysis of serum concentrations of metoprolol and its metabolite α-hydroxymetoprolol in patients with heart failure with reduced ejection fraction: a pilot study in routine health care	2
Artificial intelligence-based model for dose prediction of sertraline in adolescents: a real-world study	2
The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition	2
Effects of anti-inflammatory treatment on efficacy of selective laser trabeculoplasty: a systematic review and meta-analysis	2
Effect of laparoscopic sleeve gastrectomy on drug pharmacokinetics	2
Melflufen for the treatment of multiple myeloma	2
Recent advances and future perspectives in the pharmacological treatment ofCandida aurisinfections	2